-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Downgrades CG Oncology to Sector Perform, Raises Price Target to $97

Benzinga·11/17/2026 14:23:34
Listen to the news
RBC Capital analyst Leonid Timashev downgrades CG Oncology (NASDAQ:CGON) from Outperform to Sector Perform and raises the price target from $80 to $97.